Evaluation of Dual Therapy in Real Life Setting in Treatment-Naive Turkish Patients with HCV Infection: A Multicenter, Retrospective Study

Gurbuz Y., Tulek N. E., Tutuncu E. E., Koruk S. T., AYGEN B., Demirturk N., ...Daha Fazla

BALKAN MEDICAL JOURNAL, cilt.33, sa.1, ss.18-26, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 1
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5152/balkanmedj.2015.15859
  • Dergi Adı: BALKAN MEDICAL JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.18-26
  • Anahtar Kelimeler: Hepatitis C, peginterferon alpha-2a, peginterferon alpha-2b, ribavirin, therapy, CHRONIC HEPATITIS-C, SUSTAINED VIROLOGICAL RESPONSE, ALPHA-2B PLUS RIBAVIRIN, PEGINTERFERON ALPHA-2A, HEPATOCELLULAR-CARCINOMA, INSULIN-RESISTANCE, COMBINATION THERAPY, TOLERABILITY, MANAGEMENT, DIAGNOSIS
  • Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Background: Before the introduction of direct-acting antivirals in the treatment of chronic hepatitis C patients, the combination of peginterferon alpha and ribavirin was the standard therapy. Observational studies that investigated sustained virological response (SVR) rates by these drugs yielded different outcomes.